Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
September 20, 2024 05:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Diamondback Energy Announces Pricing of Upsized Secondary Common Stock Offering
September 19, 2024 23:35 ET
|
Diamondback Energy, Inc.
MIDLAND, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today the upsize and pricing of an underwritten public offering of 12,770,000...
Richtech Robotics Introduces Scorpion, an AI-Powered Single-Arm Beverage Service Robot, and Announces Distribution Partnership for 500 Robots Over Five Years
September 19, 2024 22:45 ET
|
Richtech Robotics Inc.
Leveraging NVIDIA accelerated computing and offering personalized drinks, Scorpion is expected to save costs, generate revenue, and provide an unforgettable customer experience LAS VEGAS,...
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
September 19, 2024 20:16 ET
|
Ascendis Pharma
COPENHAGEN, Denmark, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the pricing of its underwritten public offering of 2,000,000 American Depositary Shares...
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
September 19, 2024 19:15 ET
|
Metagenomi, Inc.
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...
Kineta, Inc Transitioning from Nasdaq to OTC Markets
September 19, 2024 18:23 ET
|
Kineta, Inc.
Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously announced TuHURA Biosciences has an exclusivity right and a right of...
Astrotech Reports Fiscal Year 2024 Financial Results
September 19, 2024 17:30 ET
|
Astrotech Corporation
AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2024. ...
Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
September 19, 2024 17:25 ET
|
Cayson Acquisition Corp.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s...
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
September 19, 2024 17:24 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
VirTra Sets 2024 Annual Meeting of Shareholders for Monday, October 21, 2024
September 19, 2024 17:18 ET
|
VirTra, Inc.
CHANDLER, Ariz., Sept. 19, 2024 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators, firearms training...